Drug intelligence / Profile preview

butalbital

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Butalbital is a short-to-intermediate acting barbiturate used primarily for the symptomatic treatment of tension-type (muscle contraction) headaches. It is most commonly administered in combination with other agents such as acetaminophen or aspirin and caffeine. Butalbital acts as a central nervous system depressant by binding to a distinct site on the Gamma-aminobutyric acid type A receptor (GABAA receptor) complex, increasing chloride ion influx and enhancing inhibitory neurotransmission. This results in sedative, muscle-relaxing, and anxiolytic effects that help relieve headache symptoms. Butalbital has a narrow therapeutic index and can be habit-forming; it is not indicated for migraine headaches due to lack of evidence for efficacy.

Brand names
FiorinalFioricetEsgicOrbivan
Other names
5-allyl-5-isobutylbarbituric acid
02

Targets

AMPAR (AMPA receptor)GABRR (GABA-A receptor subunit rho)

Beyond the preview

Go deeper on butalbital.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on butalbital.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call